www.email.biopharminternational.com Open in urlscan Pro
2606:2c40::c73c:67e4  Public Scan

URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-...
Submission: On February 27 via api from SA — Scanned from DE

Summary

This website contacted 2 IPs in 1 countries across 2 domains to perform 8 HTTP transactions. The main IP is 2606:2c40::c73c:67e4, located in United States and belongs to CLOUDFLARESPECTRUM Cloudflare, Inc., US. The main domain is www.email.biopharminternational.com.
TLS certificate: Issued by GTS CA 1P5 on January 1st 2024. Valid for: 3 months.
This is the only time www.email.biopharminternational.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
6 2606:2c40::c7... 209242 (CLOUDFLAR...)
2 2606:4700::68... 13335 (CLOUDFLAR...)
8 2
Apex Domain
Subdomains
Transfer
6 biopharminternational.com
www.email.biopharminternational.com
51 KB
2 hubspotemail.net
hs-24460541.f.hubspotemail.net — Cisco Umbrella Rank: 737732
5 KB
8 2
Domain Requested by
6 www.email.biopharminternational.com www.email.biopharminternational.com
2 hs-24460541.f.hubspotemail.net www.email.biopharminternational.com
8 2

This site contains links to these domains. Also see Links.

Domain
www.biopharminternational.com
globalmeet.webcasts.com
www.linkedin.com
twitter.com
Subject Issuer Validity Valid
www.email.biopharminternational.com
GTS CA 1P5
2024-01-01 -
2024-03-31
3 months crt.sh
hubspotemail.net
Cloudflare Inc ECC CA-3
2023-04-01 -
2024-03-31
a year crt.sh

This page contains 1 frames:

Primary Page: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Frame ID: 10B9CFDF416FB34A7ABD7B94790F795B
Requests: 8 HTTP requests in this frame

Screenshot

Page Title

[Executive Summary] Factors to Consider When Determining the Best Approach for Constructing a New Facility

Page Statistics

8
Requests

100 %
HTTPS

100 %
IPv6

2
Domains

2
Subdomains

2
IPs

1
Countries

56 kB
Transfer

86 kB
Size

2
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

8 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
www.email.biopharminternational.com/
40 KB
6 KB
Document
General
Full URL
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
56a4c1536c6944a95a0e08b4d325b3469167cbb22fee3c29e27ba5bcf67f31a0
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

access-control-allow-credentials
false
alt-svc
h3=":443"; ma=86400
cache-control
s-maxage=7200,max-age=5
cache-tag
CT-158031526951,P-24460541,PGS-ALL,SW-4
cf-cache-status
HIT
cf-ray
85bd85e1ea3d3a6c-FRA
content-encoding
br
content-security-policy
upgrade-insecure-requests
content-type
text/html;charset=utf-8
date
Tue, 27 Feb 2024 04:00:49 GMT
edge-cache-tag
CT-158031526951,P-24460541,PGS-ALL,SW-4
last-modified
Tue, 27 Feb 2024 03:54:38 GMT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
referrer-policy
no-referrer-when-downgrade
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=mI5aWWJW%2FmeUZ5moF2%2FIPo%2F9D4GRFklM2c7hyvVItAOqCiWpH8%2BZrjWBi1AOYG38CCgGHE6bHIKLW%2B1RdQn4ZnLxcMLa7%2B5a%2BcdfCsI5uXpvSFS31P1MPRw2N9mp8PDnH7rFzovHK%2F97%2Fm83EsVZj9Z%2B5GG%2BTvAzyyXZc72VCXUe"}],"group":"cf-nel","max_age":604800}
server
cloudflare
strict-transport-security
max-age=31536000
vary
origin, Accept-Encoding
x-content-type-options
nosniff
x-envoy-upstream-service-time
191
x-evy-trace-listener
listener_https
x-evy-trace-route-configuration
listener_https/all
x-evy-trace-route-service-name
envoyset-translator
x-evy-trace-served-by-pod
iad02/cms-40-49-td/envoy-proxy-6d8575499-clpm6
x-evy-trace-virtual-host
all
x-hs-cache-config
BrowserCache-5s-EdgeCache-7200s
x-hs-content-id
158031526951
x-hs-hub-id
24460541
x-hubspot-correlation-id
41d01405-c4e4-4770-8340-54454827ff5d
x-request-id
41d01405-c4e4-4770-8340-54454827ff5d
x-trace
2B2427F78073A18A42D3F07F08EF0848A7ED45B034000000000000000000
header.jpg
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/
10 KB
10 KB
Image
General
Full URL
https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/header.jpg?upscale=true&width=1200&upscale=true&name=header.jpg
Requested by
Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
91072f71582cd71a09dd3a0237a17e4eab372b22fbf74bd4db425d63864b41b8
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 04:00:49 GMT
via
1.1 45dddc65ba3da4a1716d9c10f4aaaa08.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag
F-154185516409,FD-154184359988,P-24460541,FLS-ALL
alt-svc
h3=":443"; ma=86400
content-length
9832
cf-resized
internal=ok/m q=0 n=732+0 c=1+15 v=2024.1.3 l=9832
last-modified
Wed, 24 Jan 2024 17:49:06 GMT
cf-bgj
imgq:86,h2pri
server
cloudflare
etag
"cf_EHWw30MS9stItlVvzjQd8Mjp_JT3RFRkAkfKe_HDQ:762f1dc63e3952c5bf89506ff93f2253"
vary
Accept, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=%2B%2FvhJJwNAHElIix5ZMcdM%2B0M1Ef96umnxN4bgyteM2BFohhnpL%2FwkO9Rtk9SHEVk27LcCg%2FhSsR3PmZ%2F83jGBiYLX%2BSWvwrIKyuYSP6eHSBk87turdz6%2Bks4Kz7%2BHaF%2BTzOO3sLomrhSGwo6akKkMdBg8AYyFkRBQSal402j0Gqs"}],"group":"cf-nel","max_age":604800}
content-type
image/webp
access-control-allow-origin
*
cache-control
s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges
bytes
cf-ray
85bd85e2fac93a6c-FRA
summaryCover.jpg
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/
6 KB
7 KB
Image
General
Full URL
https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/summaryCover.jpg?upscale=true&width=300&upscale=true&name=summaryCover.jpg
Requested by
Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
86a90202509aabe17633df642feb14367d9aa52c6574ef3a9896243002481b42
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 04:00:49 GMT
via
1.1 47140f009c2bd3561cd6dde4003253e2.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag
F-154186249297,FD-154184359988,P-24460541,FLS-ALL
alt-svc
h3=":443"; ma=86400
content-length
6634
cf-resized
internal=ok/m q=0 n=745+0 c=0+5 v=2024.1.3 l=6634
last-modified
Wed, 24 Jan 2024 17:54:06 GMT
cf-bgj
imgq:86,h2pri
server
cloudflare
etag
"cfVDyIxsnILEgvLvNrPg5Jmwk9Pv3fHRErO2kJZaYSDQ:a6dec232e42e53673d7a6e5051543bd3"
vary
Accept, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ReiYeK5EPagKw4jiFRCWSDUUKevLR%2BLod1DZuXrymfuqF8IiRwswAjrsKxYJa9cM0pBg1ZtCYI1FypS1753MpsnqXql5BIlXvzfYt5xCsgcCil%2BikRjWD06lbwU23TDvSe9I6qiyIkfWJvOwRLDvb1krFdbCMc%2B%2F57JySlp6o0mJ"}],"group":"cf-nel","max_age":604800}
content-type
image/webp
access-control-allow-origin
*
cache-control
s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges
bytes
cf-ray
85bd85e2faca3a6c-FRA
regPage.jpg
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/
7 KB
8 KB
Image
General
Full URL
https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/regPage.jpg?upscale=true&width=300&upscale=true&name=regPage.jpg
Requested by
Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
c3e892c2989a747ee3dcaf81db88dee956adc2483b2a369efe17a3b76926fe38
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 04:00:49 GMT
via
1.1 256cd380c9790a2b71d68709829caa18.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag
F-154187353443,FD-154184359988,P-24460541,FLS-ALL
alt-svc
h3=":443"; ma=86400
content-length
7502
cf-resized
internal=ok/m q=0 n=859+0 c=0+20 v=2024.1.3 l=7502
last-modified
Wed, 24 Jan 2024 17:54:04 GMT
cf-bgj
imgq:86,h2pri
server
cloudflare
etag
"cfuZWlGtL5qHujKFhxwc1gfVw-Pv3fHRErO2kJZaYSDQ:0ca75b61a4741c3d9be12f7bb659b144"
vary
Accept, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=feNfsMKKvfsxSBKimbKE9ml1mTh3NDt9UDjs0yv2DjLQRYrBKx%2BcIaNMUYWwtYUTEVzyqkHN2d9boJyzP4GyS1sxhjakR%2FpV5IYKn3fE79LSvzIaur0ap7feNzT39svsrSwGBEevlIG3tRpIEZd4VT%2Bj%2FJ0beomIejANj9nJL48S"}],"group":"cf-nel","max_age":604800}
content-type
image/webp
access-control-allow-origin
*
cache-control
s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges
bytes
cf-ray
85bd85e2facb3a6c-FRA
biopharm.png
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/
7 KB
7 KB
Image
General
Full URL
https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/biopharm.png?upscale=true&width=450&upscale=true&name=biopharm.png
Requested by
Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
5e0d94875809da71c3218cc23bbd1d83b5d7ba002feb93bbc26f31425bb02b79
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 04:00:49 GMT
via
1.1 362b298821815168614ba932732916ea.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag
F-154184360027,FD-154184359988,P-24460541,FLS-ALL
alt-svc
h3=":443"; ma=86400
content-length
6784
cf-resized
internal=ok/m q=0 n=898+0 c=5+22 v=2024.1.3 l=6784
last-modified
Wed, 24 Jan 2024 17:49:01 GMT
cf-bgj
imgq:86,h2pri
server
cloudflare
etag
"cfcYaBnjibSyzIb964AeHKe0WP4W08S3YyiQfIvN6zDQ:14b104925e1f868d0fdaee557013c255"
vary
Accept, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=3xo56jw97cnyCkfk7tQJm8lYEDTICfrJRlEmkaG3N331l6IU3SKKxDtacJfuQfpg7fkvuHW23APvlGs%2B1b9xmF8eg9cszrwaXvfLWP1b50fsJIctL9nj3i5wrG3gzLyQaVDkjEsv654bbaKlghqU5%2FXiUdsE46D6kbGy8PhuMBUH"}],"group":"cf-nel","max_age":604800}
content-type
image/webp
access-control-allow-origin
*
cache-control
s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges
bytes
cf-ray
85bd85e2facc3a6c-FRA
gcon.png
www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/
12 KB
12 KB
Image
General
Full URL
https://www.email.biopharminternational.com/hs-fs/hubfs/Brand%20Assets/BioPharm%20International/Z_Creative/Executive%20Summaries/2024/092623_GCON/gcon.png?upscale=true&width=450&upscale=true&name=gcon.png
Requested by
Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:2c40::c73c:67e4 , United States, ASN209242 (CLOUDFLARESPECTRUM Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
8e1ea1fb3b1c2f4df0142fcd87ce21d7dd0726b38963cceaaf5a5444bd705ecb
Security Headers
Name Value
Content-Security-Policy default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 04:00:49 GMT
via
1.1 e328b143eb69c36369a2def78300d502.cloudfront.net (CloudFront)
x-content-type-options
nosniff
cf-cache-status
HIT
nel
{"success_fraction":0.01,"report_to":"cf-nel","max_age":604800}
content-security-policy
default-src 'none'; navigate-to 'none'; form-action 'none'; upgrade-insecure-requests
cache-tag
F-154185288525,FD-154184359988,P-24460541,FLS-ALL
alt-svc
h3=":443"; ma=86400
content-length
12002
cf-resized
internal=ok/m q=0 n=930+0 c=5+40 v=2024.1.3 l=12002
last-modified
Wed, 24 Jan 2024 17:48:57 GMT
cf-bgj
imgq:86,h2pri
server
cloudflare
etag
"cf8Cxf4guvnhuedmpwn1SsAMKq4W08S3YyiQfIvN6zDQ:a07fc58be842744ab9aed062988afd64"
vary
Accept, Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xXnvuqQQ16ajDASdcOk3MN8%2B3DxiAxVPhO%2BFYyWULWNfkT%2BYH5%2FoOIMnednOfzDCDOEiB8JHzw9LwZmHdiFRQSCSsXCXglyl1ppssyecElP91x7rvsK3TiP%2Fv%2F5lATCPFMzBgY%2BADHYrEWUEmcI32263lKanHorLdmhKx95d0jND"}],"group":"cf-nel","max_age":604800}
content-type
image/webp
access-control-allow-origin
*
cache-control
s-maxage=2592000, max-age=1209600, stale-while-revalidate=900
accept-ranges
bytes
cf-ray
85bd85e2facd3a6c-FRA
linkedin_circle_color.png
hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/
1 KB
1 KB
Image
General
Full URL
https://hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/linkedin_circle_color.png
Requested by
Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6811:ddb1 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
a4d09d81cd7505339ba3ab4a685d1fea0dc3130155a49e5c9123f2b5fad1d149
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 04:00:49 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 bc3ecf5f025b0be9b8c39c5dd2dace2e.cloudfront.net (CloudFront)
cf-cache-status
HIT
x-amz-version-id
sVwKg68BgiHAiI1gZ9UYWF67w57kzLrn
age
3423191
x-amz-cf-pop
FRA60-P6
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-replication-status
COMPLETED
content-length
1116
last-modified
Wed, 20 Dec 2023 15:32:09 GMT
server
cloudflare
etag
"27594239f030ba18f4fde5d48917d57d"
vary
Accept-Encoding
content-type
image/png
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
85bd85e32f233647-FRA
x-amz-cf-id
cP1zetrxvb0WaX3KqEfDNZ_PzJwM-xXn9Z5NLNk5Xqb438-voN1s2Q==
expires
Wed, 26 Feb 2025 04:00:49 GMT
twitter_circle_color.png
hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/
3 KB
4 KB
Image
General
Full URL
https://hs-24460541.f.hubspotemail.net/hs/hsstatic/TemplateAssets/static-1.262/img/hs_default_template_images/modules/Follow+Me+-+Email/twitter_circle_color.png
Requested by
Host: www.email.biopharminternational.com
URL: https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6811:ddb1 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
fa65d03e7627af254881f94bd0e4446f246ea36c0a40d8365cd64f1f22670613
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.email.biopharminternational.com/executive-summary-factors-to-consider-when-determining-the-best-approach-for-constructing-a-new-facility02262024
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 04:00:49 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
via
1.1 146c0f4d7da9f5b3108ac41c3becbb82.cloudfront.net (CloudFront)
cf-cache-status
HIT
x-amz-version-id
XEZ0EE1eMPmtjcGiB5HyqF1VItz1lzhS
age
3422900
x-amz-cf-pop
FRA60-P6
x-amz-server-side-encryption
AES256
x-cache
Hit from cloudfront
x-amz-replication-status
COMPLETED
content-length
3291
last-modified
Wed, 20 Dec 2023 15:32:09 GMT
server
cloudflare
etag
"bc7502d9383cee242e9d89f57e912878"
vary
Accept-Encoding
content-type
image/png
cache-control
public, max-age=31536000
accept-ranges
bytes
cf-ray
85bd85e32f253647-FRA
x-amz-cf-id
A-7s2zhmkXTpk3KRvOxZctMwZP6nRE45hc471L5qG030aAsWJBzVZQ==
expires
Wed, 26 Feb 2025 04:00:49 GMT

Verdicts & Comments Add Verdict or Comment

0 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

2 Cookies

Domain/Path Name / Value
.www.email.biopharminternational.com/ Name: __cf_bm
Value: JhWrHeyYw1ypg_1BnSZd7t07e3cS8LG5kyZAlJLIDP4-1709006449-1.0-AUXjdxDs8t2OWq2GxMrkfPuAmbaYtLNxLR0EIVMOoV000T55DBlfWdPf3SA/pVhgYNAIzqqiWy+hutv9USpEfk4=
.www.email.biopharminternational.com/ Name: __cfruid
Value: de79fb2632692b44d7765ec962dfab8aed017a7b-1709006449

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy upgrade-insecure-requests
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff